Patents
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
07/2008
07/03/2008US20080160627 Environmental Sensitive Fluorogenic Compounds and Their Application for Singlet Oxygen and Protein Detection
07/02/2008EP1939192A1 Cyclopentanone derivatives, method of synthesis and uses thereof
07/02/2008EP1939185A1 New types of hetaryl-phenylendiamin-pyrimidines as protein kinase inhibitors for the treatment of cancer
07/02/2008EP1939183A1 Novel nitrogenated heterocyclic compound
07/02/2008EP1939180A1 Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial NO synthase
07/02/2008EP1663964B1 Method for the production of bisepoxides and dithiols
07/02/2008EP1495019B1 Glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof
07/02/2008EP1451181B1 Dimeric compounds and their use as anti-viral agents
07/02/2008EP1423385B1 Intermediates for preparing neuraminidase inhibitor conjugates
07/01/2008US7393858 Tetrahydropyran compounds as tachykinin antagonists
06/2008
06/26/2008WO2008074515A1 Novel hetaryl-phenylene-diamine pyrimidine as protein kinase inhibitors
06/26/2008WO2008074413A2 Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial no synthase
06/26/2008WO2008043733B1 3- (benzo [d] [1,3] dioxol-5-ylmethyl) -4- (thio) oxo-2- (thio) oxo-azolidin-5-ylidene derivatives as antibacterial agents
06/26/2008US20080153872 Bis-(Coumarin) Compounds With Anti-Inflammatory Activity
06/25/2008EP1935893A1 Total synthesis of pladienolide b and pladienolide d
06/25/2008EP1934181A2 Kinase inhibitors
06/25/2008EP1730140B1 Opioid receptor antagonists
06/24/2008US7390898 Cytotoxic agents containing novel potent taxanes and their therapeutic use
06/24/2008US7390815 Pyrazole compounds useful as protein kinase inhibitors
06/19/2008WO2008071455A1 Bicyclic acyltryptophanols
06/19/2008WO2008071451A1 Dihydropyridine derivatives useful as protein kinase inhibitors
06/19/2008WO2008071405A1 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides
06/19/2008WO2008071397A1 Aromatic 1,4-di-carboxylamides and their use
06/19/2008WO2008044217A3 2-aminocarbonyl-pyridine derivatives
06/19/2008WO2008010022A3 A process for preparation of racemic nebivolol
06/19/2008US20080146660 Androgen receptor antagonists; certain cancers such as colon, skin and prostate cancer, baldness, hirsutism, behavioral disorders, acne, and inhibition of spermatogenesis if so desired
06/19/2008US20080146589 Chromenone derivatives
06/19/2008CA2672167A1 Dihydropyridine derivatives as useful as protein kinase inhibitors
06/19/2008CA2671970A1 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides
06/18/2008EP1932834A1 Aromatic 1,4-DI-Carboxylamides and their use
06/18/2008EP1931645A2 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors
06/18/2008EP1443937B1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
06/18/2008CN101200465A Decahydronaphthalene compounds and medical uses thereof
06/17/2008CA2395193C Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors
06/12/2008WO2008068266A1 Antibacterial quinoline derivatives
06/12/2008WO2008067710A1 Substituted cyclohexane compounds, preparation methods and medicine uses thereof
06/12/2008WO2008067709A1 Substituted cyclobutane compounds, preparation methods and pharmaceutical uses thereof
06/12/2008WO2008042688A3 Phlorizin analogs as inhibitors of sodium glucose co-transporter 2
06/12/2008US20080139728 Composition Containing a Hydrogenated Bisglycidyl Ether and a Cross-Linking Agent
06/12/2008CA2668515A1 Antibacterial quinoline derivatives
06/11/2008EP1930313A2 Preparation of alpha-aminoketones
06/11/2008EP1930309A2 Preparation of alpha-hydroxyketones
06/11/2008EP1928865A1 Novel high affinity thiophene-based and furan-based kinase ligands
06/11/2008EP1928859A1 Pyrazole derivates as cannabinoid receptor modulators
06/11/2008EP1451184B1 Dimeric compounds and their use as anti-viral agents
06/11/2008EP1451182B1 Dimeric compounds and their use as anti-viral agents
06/11/2008CN101195616A Compound with antineoplastic activity, production method and application thereof
06/10/2008US7384975 Substituted furochromenes, preparation thereof and their antiinflammatory action
06/10/2008US7384947 Treating cancer with anticarcinogenic agents 3-Amino-9-chloro-5,6,7,8-tetrahydro-naphtho[2,3-b]furan-2-yl))-(2-methyl-pyridin-3-yl)-methanone; antiproliferative agents
06/10/2008US7384943 Substituted chroman derivatives
06/05/2008WO2008064827A2 Process for preparing nebivolol
06/05/2008WO2008064826A1 Process for preparing nebivolol
06/05/2008CA2835833A1 Process for preparing nebivolol
06/05/2008CA2668436A1 Process for preparing nebivolol
06/05/2008CA2667919A1 Process for preparing nebivolol
06/04/2008EP1737847B1 Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
06/04/2008EP1237887B1 9-(piperazinylalkyl)carbazoles as bax-modulators
06/04/2008CN101193860A 有机化合物 Organic compounds
06/04/2008CN101193631A Inhibitors of soluble adenylate cyclase
06/03/2008US7381824 Quinoline derivatives
05/2008
05/29/2008WO2008063207A1 Method for purifying dianhydrides
05/29/2008US20080125587 Synthesis of triazole compounds that modulate HSP90 activity
05/28/2008EP1924564A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators
05/28/2008EP1577294A4 S-substituted n-1- (hetero)aryl alkyl-n - (hetero)aryl alkylysothiocarbamides, method for the production thereof, physiologically active s-substituted n-1- (hetero )aryl alkyl-n - (hetero)aryl alkylysothiocarbamides,a pharmaceutical compound and curing method
05/28/2008EP1373260B1 Dibenzo c chromen-6-one derivatives as anti-cancer agents
05/28/2008EP1218360B1 Triazine kinase inhibitors
05/28/2008CN101189226A Piperidin-4-yl-amide derivatives and their use as SST receptor subtype 5 antagonists
05/28/2008CN101186598A 1-oxy-acetyl inula Britannica lactone derivative, preparation method thereof and application of the same in preparing cancer-curing medicine
05/28/2008CN101185611A Technique for preparing silybin fine particles by using supercritical fluid crystallization technology
05/28/2008CN100390167C Total synthesis of myriaporones
05/27/2008US7378421 Chromenone derivatives
05/27/2008US7378412 Pharmaceutical compounds
05/22/2008WO2008061134A1 Derivatives of 18-amino substituted analogs of the geldamycin hydroquinon with cytotoxic activity for the treatment of cancer
05/22/2008WO2008061016A1 N-substituted piperidinyl 4 -arylsulfonamides as modulators of the secreted frizzled related protein- 1
05/22/2008WO2008059854A1 Piperidine derivatives or salts thereof
05/22/2008WO2008059513A2 Compounds suitable as modulators of hdl
05/22/2008WO2008059339A2 Isoquinoline derivatives as vanilloid receptor modulators
05/22/2008WO2008040528A3 Process for preparing nebivolol
05/22/2008WO2007147770A3 Substituted phenyl methanone derivatives
05/22/2008US20080119490 Viral Polymerase Inhibitors
05/22/2008CA2669820A1 Derivatives of 18-amino substituted analogs of the geldamycin hydroquinon with cytotoxic activity for the treatment of cancer
05/22/2008CA2669635A1 Piperidine derivative or salt thereof
05/21/2008EP1603893B1 Ep4 receptor antagonists
05/21/2008EP1183253B1 C7 ester substituted taxanes as antitumor agents
05/21/2008CN101184749A Spirocyclic heterocyclic derivatives and methods of their use
05/21/2008CN101181469A Osteosporosis-resistance chinese medicine extract as well as extracting technique and usage of active component
05/20/2008US7375219 neuronal nitric oxide synthase (nNOS) isoform inhibitors; 2-ethyl-1-(1H-indol-5-yl)-isothiourea; neurogenerative disorders, stroke, reperfusion injury, head trauma, migraine headache, neuropathic pain, drug abuse, hyperalgesia
05/20/2008CA2432223C Pyrazole compounds useful as protein kinase inhibitors
05/15/2008WO2008058037A1 Compounds and compositions as protein kinase inhibitors
05/15/2008WO2008056150A1 Heterocyclyc sulfonamides having edg-i antagonistic activity
05/15/2008WO2008055945A1 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
05/15/2008US20080114056 Analgesics; e.g. osteoarthritis, cancer pain, myofascial pain (muscular injury, fibromyalgia) and perioperative pain, inflammatory pain; 7-(hydroxy, ether, ester, amide, or carbamate)-3-(substituted phenyl)-chromen-4-ones; chemical synthesis
05/15/2008US20080113999 Use of Amidomethyl-Substituted 2-(4-Sulfonylamino)-3-Hydroxy-3,4-Dihydro-2H-Chromen-6-yl-Compounds in the Treatment of Cardiac Arrhythmia and Other Disease States
05/15/2008CA2668785A1 Heterocyclyc sulfonamides having edg-i antagonistic activity
05/15/2008CA2668190A1 Compounds and compositions as protein kinase inhibitors
05/14/2008EP1921076A1 systhesis of procyanidin B2
05/14/2008EP1919907A2 Heterocyclic compound
05/14/2008EP1919452A2 Application of a bioactive agent to a substrate
05/14/2008EP1919451A2 Application of a bioactive agent in a solvent composition to produce a target particle morphology
05/14/2008CN101180295A Tetrahydropyrane derivatives comprising several rings containing oxygen and method for the production thereof
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 120